首页> 美国卫生研究院文献>OncoTargets and therapy >Efficacy and safety of sorafenib versus apatinib in the treatment of intermediate and advanced hepatocellular carcinoma: a comparative retrospective study

【2h】

Efficacy and safety of sorafenib versus apatinib in the treatment of intermediate and advanced hepatocellular carcinoma: a comparative retrospective study

机译：索拉非尼和阿帕替尼治疗中晚期肝细胞癌的疗效和安全性：一项回顾性比较研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectiveTo compare the efficacy and safety profiles of sorafenib and apatinib in patients with intermediate- and advanced-stage hepatocellular carcinoma (HCC).

机译：目的比较索拉非尼和阿帕替尼在中晚期肝细胞癌（HCC）中的疗效和安全性。

著录项

期刊名称 OncoTargets and therapy
作者
Yizhuo Wang; Qing Gou; Rongde Xu; Xiaoming Chen; Zejian Zhou;
展开▼
作者单位

展开▼
年(卷),期 2018(11),-1
年度 2018
页码 3407–3413
总页数 7
原文格式 PDF
正文语种
中图分类应用微生物学;肿瘤学;
关键词
observational HCC sorafenib apatinib overall survival progression-free survival;

机译：观察性;HCC;索拉非尼;阿帕替尼;总生存期;无进展生存期;

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of sorafenib versus apatinib in the treatment of intermediate and advanced hepatocellular carcinoma: a comparative retrospective study [J] . Yizhuo Wang, Qing Gou, Rongde Xu, OncoTargets and therapy . 2018,第1期

机译：索拉非尼与阿帕替尼治疗中，晚期肝细胞癌的疗效和安全性：一项回顾性比较研究
2. Efficacy and safety of sorafenib versus apatinib in the treatment of intermediate and advanced hepatocellular carcinoma: a comparative retrospective study [J] . Yizhuo Wang, Qing Gou, Rongde Xu, OncoTargets and therapy . 2018,第1期

机译：索拉非尼与阿帕替尼治疗中，晚期肝细胞癌的疗效和安全性：一项回顾性比较研究
3. Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study [J] . Liyun Zheng, Shiji Fang, Fazong Wu, Frontiers in Molecular Biosciences . 2021,第a期

机译：TACE与Sorafenib加上免疫检查点抑制剂的疗效和安全性用于治疗中间和晚期TACE - 难治性肝细胞癌：回顾性研究
4. Magnetically Targeted Delivery of Sorafenib Through Magnetic Solid Lipid Nanoparticles Towards Treatment of Hepatocellular Carcinoma [C] . F. Vischio, N. Depalo, R. M. Iacobazzi, NATO Advanced Study Institute on Detection, Diagnosis and Health Concerns of Toxic Chemical and Biological Agents . 2020

机译：通过磁性固体脂质纳米粒子致磁性固体脂质纳米粒子对肝细胞癌治疗的磁性靶向递送
5. Poly(lactide-co-glycolide) Microspheres for Localized, Magnetic Resonance Imaging Monitored, Transcatheter Delivery of Sorafenib to Hepatocellular Carcinoma. [D] . Chen, Jeane. 2015

机译：聚（丙交酯-共-乙交酯）微球体用于局部监测，磁共振成像监测，索拉非尼经导管输送至肝细胞癌。
6. Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study [O] . Liyun Zheng, Shiji Fang, Fazong Wu, 2020

机译：TACE与Sorafenib加上免疫检查点抑制剂的疗效和安全性用于治疗中间和晚期TACE - 难治性肝细胞癌：回顾性研究
7. Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study [O] . Liyun Zheng, Shiji Fang, Fazong Wu, 2021

机译：TACE与Sorafenib加上免疫检查点抑制剂的疗效和安全性用于治疗中间和晚期TACE - 难治性肝细胞癌：回顾性研究

Efficacy and safety of sorafenib versus apatinib in the treatment of intermediate and advanced hepatocellular carcinoma: a comparative retrospective study

摘要

著录项

相似文献

相关主题

期刊订阅